Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,365 studies match

clinicaltrialsPublishedShowing 151–200 of 1,365 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02711553	A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer	active not recruiting	Phase 2	309	Eli Lilly and CompanyINDUSTRY	18	Jul 22, 2026	clinicaltrials
NCT03786081	Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer	terminated	Phase 1 / Phase 2	214	Seagen, a wholly owned subsidiary of PfizerINDUSTRY	10	Jul 22, 2026